Senate Passes New Stem Cell Bill
But Tally Falls Short of Votes Needed to Override a Presidential Veto
Role of Stem Cells in Research continued...
The issue recently caused a split in Bush administration ranks. Last month,
National Institutes of Health (NIH) Director Elias Zerhouni, MD, called White
House limits on embryonic stem cell research "shortsighted" and
suggesting the nation would benefit if the policy were reversed.
"It is clear today that American science will be better served and the
nation will be better served if we let our scientists have access to more cell
lines," Zerhouni told a Senate committee on March 19.
Zerhouni later played down the importance of the remarks. But supporters of
the research on Capitol Hill quickly pointed out that it was the first time
Zerhouni, a Bush political appointee, had publicly criticized the policy after
years of voicing support for it.
It is unclear whether the Senate will muster enough votes to override a
veto. Sen. Tim Johnson, D-N.D., supports the repeal but did not vote because he
is recovering from a brain hemorrhage. Supporters are hoping to put enough
pressure on lawmakers in moderate states in the hopes that one or two more will
The House is likely to soon vote again on the issue. The Senate added a
provision to its bill requiring the NIH to fund research into methods of
extracting human stem cells without destroying embryos. Before the bill goes to
the president, the House will have to pass its bill with the new provision